Mechanisms of Resistance to MEK Inhibitors (RAS–MAPK Pathway) in Malignant Peripheral Nerve Sheath Tumors and Their Precursor Lesions (Plexiform Neurofibromas) Associated with Neurofibromatosis Type 1

Sergey I. Sologov, Diana Sologova, Denis Dubinin, George Anikin, Nana Bekhorashvili, Maria Rayisyan, Elena Krylova, Milada Yarkova, Ekaterina M. Grigorevskikh, Elena Smolyarchuk, Susanna Sologova · 2026

Read Mechanisms of Resistance to MEK Inhibitors (RAS–MAPK Pathway) in Malignant Peripheral Nerve Sheath Tumors and Their Precursor Lesions (Plexiform Neurofibromas) Associated with Neurofibromatosis Type 1 by Sergey I. Sologov, Diana Sologova, Denis Dubinin, George Anikin, Nana Bekhorashvili, Maria Rayisyan, Elena Krylova, Milada Yarkova, Ekaterina M. Grigorevskikh, Elena Smolyarchuk, Susanna Sologova (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605925.txt.

Description

Sologov leads a large team reviewing drug resistance in nerve tumors, in work from twenty twenty-six. The tumors link to a genetic condition called neurofibromatosis type one. Drugs that block the MEK signal path are the only approved targeted option, yet gains are often partial and short lived.

In the malignant form of these tumors, MEK drugs alone do not work well in clinic. Past reports on escape routes are scattered single studies with no joint view. The review brings those reports together for both the benign precursor growths and the cancers. The goal is to map how tumors evade the drugs, so better drug pairs can be designed.

Catalog record

CREATORSergey I. Sologov, Diana Sologova, Denis Dubinin, George Anikin, Nana Bekhorashvili, Maria Rayisyan, Elena Krylova, Milada Yarkova, Ekaterina M. Grigorevskikh, Elena Smolyarchuk, Susanna Sologova
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13605925

Browse the full library · About the Tower of Babel